Research ArticleArticle
High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
Veronika Rauscher, Matthias Englbrecht, Désirée van der Heijde, Georg Schett and Axel J. Hueber
The Journal of Rheumatology March 2015, 42 (3) 386-390; DOI: https://doi.org/10.3899/jrheum.140982
Veronika Rauscher
From the Department of Internal Medicine 3 and the Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen,
Germany; and the Department of Rheumatology, Leiden University Medical Center, Leiden,
the Netherlands.
Matthias Englbrecht
Désirée van der Heijde
Georg Schett
Axel J. Hueber
REFERENCES
- 1.↵
- 2.↵
- World Health Organization
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- de Klerk E,
- van der Heijde D,
- Landewe R,
- van der Tempel H,
- van der Linden S
- 11.↵
- 12.↵
- Gilworth G,
- Emery P,
- Gossec L,
- Vliet Vlieland TP,
- Breedveld FC,
- Hueber AJ,
- et al.
- 13.↵
- 14.↵
- Gossec L,
- Paternotte S,
- Aanerud GJ,
- Balanescu A,
- Boumpas DT,
- Carmona L,
- et al.
- 15.↵
- 16.↵
- de Klerk E,
- van der Heijde D,
- Landewé R,
- van der Tempel H,
- Urquhart J,
- van der Linden S
In this issue
The Journal of Rheumatology
Vol. 42, Issue 3
1 Mar 2015
High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
Veronika Rauscher, Matthias Englbrecht, Désirée van der Heijde, Georg Schett, Axel J. Hueber
The Journal of Rheumatology Mar 2015, 42 (3) 386-390; DOI: 10.3899/jrheum.140982